Thiamine/ribofla/niacinami/dexpanth/pyridox/hydroxycoba recall: Sterility Concern
THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/HYDROXYCOBAL 25MG/25MG/25MG/25MG/25MG/20MG/ML (3ML VIAL) INJECTABLE…
Why was Thiamine/ribofla/niacinami/dexpanth/pyridox/hydroxycoba recalled?
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
t20221116@36 t20221121@42 t20221021@32
- Product
- THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/HYDROXYCOBAL 25MG/25MG/25MG/25MG/25MG/20MG/ML (3ML VIAL) INJECTABLE…
- Recalling firm
- Pharmacy Innovations
- Quantity
- N/A
- Distribution
- Nationwide in the USA
- Recall date
- February 1, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)